Stephanie Federico

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

ChemMedChem

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

RSC medicinal chemistry

Università degli Studi di Trieste

Università degli Studi di Trieste (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Trieste Nov 01 2012

Italy

Researcher :: Dipartimento di Scienze Chimiche e Farmaceutiche

Università degli Studi di Trieste Jan 01 2011 - Oct 31 2012

Italy

Post-doc :: Dipartimento di Scienze Chimiche e Farmaceutiche

Education History

Università degli Studi di Trieste Jan 01 2008 - Dec 31 2010

Italy

PHD :: Dipartimento di Scienze Chimiche e Farmaceutiche

Università degli Studi di Trieste Sep 01 2002 - Nov 19 2007

Italy

MSC :: Facoltà di Farmacia

Publications

Sara Calenda, Daniela Catarzi, Flavia Varano, Erica Vigiani, Rosaria Volpini, Catia Lambertucci, Andrea Spinaci, Letizia Trevisan, Ilenia Grieco, Stephanie Federico, Giampiero Spalluto, Gianluca Novello, Veronica Salmaso, Stefano Moro, Vittoria Colotta
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Sara Calenda, Daniela Catarzi, Flavia Varano, Erica Vigiani, Rosaria Volpini, Catia Lambertucci, Andrea Spinaci, Letizia Trevisan, Ilenia Grieco, Stephanie Federico, Giampiero Spalluto, Gianluca Novello, Veronica Salmaso, Stefano Moro, Vittoria Colotta
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Teresa Gianferrara, Matteo Pavan, Davide Bassani, Fabrizio Vincenzi, Silvia Pasquini, Giovanni Bolcato, Katia Varani, Giampiero Spalluto, Stephanie Federico, Stefano Moro
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors. ChemMedChem (2023)
Andrea Spinaci, Michela Buccioni, Daniela Catarzi, Chang Cui, Vittoria Colotta, Diego Dal Ben, Eleonora Cescon, Beatrice Francucci, Ilenia Grieco, Catia Lambertucci, Gabriella Marucci, Davide Bassani, Matteo Pavan, Flavia Varano, Stephanie Federico, Giampiero Spalluto, Stefano Moro, Rosaria Volpini
"Dual Anta-Inhibitors" of the A 2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Veronica Salmaso, Margherita Persico, Tatiana Da Ros, Giampiero Spalluto, Sonja Kachler, Karl-Norbert Klotz, Stefano Moro, Stephanie Federico
Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors. Biomolecules 13 (11) (2023)
Claudia Albertini, Alessandra Salerno, Silvia Atzeni, Elisa Uliassi, Francesca Massenzio, Annalisa Maruca, Roberta Rocca, Marko Mecava, Filomena S G Silva, Débora Mena, Pedro Valente, Ana I Duarte, Daniel Chavarria, Maicol Bissaro, Stefano Moro, Stephanie Federico, Giampiero Spalluto, Ondrej Soukup, Fernanda Borges, Stefano Alcaro, Barbara Monti, Paulo J Oliveira, José Carlos Menéndez, Maria Laura Bolognesi
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis. ACS chemical neuroscience 13 (15) (2022)
Davide Bassani, Matteo Pavan, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese, Stefano Moro
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? International journal of molecular sciences 23 (9) (2022)
Giovanni Bolcato, Eleonora Cescon, Matteo Pavan, Maicol Bissaro, Davide Bassani, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese, Stefano Moro
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ. International journal of molecular sciences 22 (18) (2021)
Florent Pineux, Stephanie Federico, Karl-Norbert Klotz, Sonja Kachler, Carine Michiels, Mattia Sturlese, Maurizio Prato, Giampiero Spalluto, Stefano Moro, Davide Bonifazi
Targeting G Protein-Coupled Receptors with Magnetic Carbon Nanotubes: The Case of the A3 Adenosine Receptor. ChemMedChem 15 (20) (2020)
Stephanie Federico, Enrico Margiotta, Stefano Moro, Sonja Kachler, Karl-Norbert Klotz, Giampiero Spalluto
Potent and selective A3 adenosine receptor antagonists bearing aminoesters as heterobifunctional moieties. RSC medicinal chemistry 12 (2) (2020)
Stephanie Federico, Giampiero Spalluto
Functionalized ligands targeting G protein-coupled adenosine receptors. Future medicinal chemistry 11 (14) (2019)
Sara Redenti, Irene Marcovich, Teresa De Vita, Concepción Pérez, Rita De Zorzi, Nicola Demitri, Daniel I Perez, Giovanni Bottegoni, Paola Bisignano, Maicol Bissaro, Stefano Moro, Ana Martinez, Paola Storici, Giampiero Spalluto, Andrea Cavalli, Stephanie Federico
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition. ChemMedChem 14 (3) (2019)
Stephanie Federico, Enrico Margiotta, Silvia Paoletta, Sonja Kachler, Karl-Norbert Klotz, Kenneth A Jacobson, Giorgia Pastorin, Stefano Moro, Giampiero Spalluto
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example. MedChemComm 10 (7) (2019)

Stephanie Federico.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stephanie Federico